Stock Markets Slip, JLR Cuts 4,000 UK Jobs, Pharma Gains On GLP-1 Weight Loss Drugs
Stock markets faced downward pressure as rising crude oil prices and simmering US-Iran tensions weighed on investor sentiment, dragging Nifty down to 23,779 amid steep declines in IT and metal shares. In corporate developments, Jaguar Land Rover announced 4,000 job cuts in the UK over two years to save 2.3 billion dollars amid tariff pressures and cyberattack impacts. Meanwhile, the domestic pharmaceutical sector witnessed robust momentum driven by weight loss and diabetes treatments, with Eli Lilly's Mounjaro recording over 500 percent sales growth and RPG Life Sciences preparing to launch its GLP-1 drug. Ashok Leyland highlighted strong growth in defense, with revenues tripling to over 1,200 crore rupees alongside a new production facility planned in Saudi Arabia. Market expert Abhishek Basumallik shared an optimistic outlook on the pharmaceutical and chemical sectors while advising caution regarding cyclical peaks in the automotive space and evaluating the surge of new public offerings.
